Acute Myocardial Infarction Epidemiology Forecast 2026-2035

Acute myocardial infarction (AMI) remains a major cardiovascular emergency worldwide. As per Maryam Sajid et al., 2025, the condition affects nearly 3 million individuals globally, indicating a significant disease prevalence, with the United States reporting over 1 million deaths annually. According to the acute myocardial infarction epidemiology forecast, the disease burden is expected to remain substantial due to aging populations and rising cardiovascular risk factors.

Acute Myocardial Infarction Epidemiology Forecast Report Coverage

The analyst's “Acute Myocardial Infarction Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of acute myocardial infarction. It projects the future incidence and prevalence rates of acute myocardial infarction cases across various populations. The study covers age, gender, and type as major determinants of the acute myocardial infarction population. The report highlights patterns in the prevalence of acute myocardial infarction over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of acute myocardial infarction in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Acute Myocardial Infarction Understanding: Disease Overview

Acute myocardial infarction (AMI), commonly known as a heart attack, is a serious cardiovascular condition that occurs when blood flow to a part of the heart muscle is suddenly blocked, leading to tissue damage or necrosis. It most often results from the rupture of an atherosclerotic plaque in a coronary artery, followed by thrombus formation that obstructs blood flow. The lack of oxygen supply causes rapid injury to myocardial cells. AMI is generally classified into two major types: ST-elevation myocardial infarction (STEMI) and non‑ST‑elevation myocardial infarction (NSTEMI), distinguished by electrocardiographic findings and the severity of coronary artery obstruction.

Acute Myocardial Infarction Epidemiology Perspective

The acute myocardial infarction epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the acute myocardial infarction epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for acute myocardial Infarction and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Arshdeep Singh Sekhon et al., 2025, study follow-up data indicate that acute myocardial infarction incidence rises markedly with age, reaching 12.9, 38.2, and 71.2 per 1000 men across ages 30-54, compared with 2.2-13.0 per 1000 women.
• As per Iva N. Dimitrova et al., 2023, cardiovascular diseases remain the leading global cause of death, increasing from 12.1 million deaths in 1990 to 18.6 million in 2019, with ischemic heart disease responsible for approximately 49.2% of cardiovascular mortality worldwide.
• According to Dr. Arshdeep Singh Sekhon et al., 2025, around 10-16% of acute myocardial infarction cases in India occur in younger individuals, where smoking and a family history of ischemic heart disease are frequently reported risk factors.
• According to Guralwar, Chinmay et al., 2025, acute ST-segment elevation myocardial infarction accounted for 86.6% of observed cases, with strong male predominance at 81.1%. Chest pain was the most common presenting symptom, reported in 73.3% of patients.
• As per long-term observations reported by Dr. Arshdeep Singh Sekhon et al., 2025, although young patients often experience better short-term outcomes after myocardial infarction, long-term prognosis remains concerning, with elevated mortality reported even 15 years after the initial event.

Country-wise Acute Myocardial Infarction Epidemiology

The acute myocardial infarction epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiological burden of acute myocardial infarction (AMI) remains significant across major global regions. According to Ulrike Nimptsch et al., 2024, approximately 3.90 million AMI cases were estimated in the United States between 2014 and 2019, while Germany reported about 1.30 million AMI hospitalizations during the same period, with age-sex standardized hospitalization rates of 236 and 235 per 100,000 population, respectively. According to Maryam Sajid et al., 2025, nearly 116 million (1 in 2) adults in the United States have hypertension, a major risk factor for AMI, though only about one in four individuals have the condition under control. In India, according to Piyush Joshi et al., 2022, the prevalence of acute myocardial infarction among very young adults aged ≤30 years is less than 2%. These statistics highlight the substantial epidemiological burden of AMI across regions such as the United Kingdom, France, Spain, Italy, and Japan.

Acute Myocardial Infarction: Treatment Overview

Treatment of acute myocardial infarction focuses on rapidly restoring blood flow to the affected heart muscle and preventing further complications. Initial management typically includes medications such as aspirin, anticoagulants, thrombolytics, beta-blockers, and statins to reduce clot formation, relieve chest pain, and stabilize the patient. Reperfusion therapies are critical, with procedures like percutaneous coronary intervention (PCI) commonly used to open blocked coronary arteries. In severe cases, coronary artery bypass grafting (CABG) surgery may be performed. Long-term management includes lifestyle modifications, cardiac rehabilitation, and continuous pharmacological therapy to prevent recurrence.

Key Questions Answered

• What are the key findings of acute myocardial infarction epidemiology in the 8 major markets?
• What will be the total number of patients with acute myocardial infarction across the 8 major markets during the forecast period?
• What was the country-wise acute myocardial infarction epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of acute myocardial infarction patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of acute myocardial infarction during the forecast period of 2026-2035?
• What are the currently available treatments for acute myocardial infarction?
• What are the disease risks, signs, symptoms, and unmet needs of acute myocardial infarction?

Scope of the Acute Myocardial Infarction Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of acute myocardial infarction based on several factors.
• Acute Myocardial Infarction Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The acute myocardial infarction report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.